This article considers the aetiology and demographics of general conjunctival
irritation, including seasonal allergic conjunctivitis (SAC) and perennial
allergic conjunctivitis (PAC). In terms of patient management, assessment
and follow-up, guidelines need to be carefully considered for each type
of condition as does the finer details of legislation relevant to the use of
different drugs in eye brighteners, decongestants, decongestant / topical
antihistamines, and oral antihistamines, as well as mast cell stabilisers.
Special consideration will be given to access to topical ocular antihistamines
and a topical NSAID by additional supply (AS level) optometrists.
|Publication status||Published - 1 Oct 2010|
- vision sciences